Phase II Study of Vincristine Sulfate Liposomes Injection in Patients with Metastatic Uveal Melanoma
Bedikian AY, Sato T, Kim KB, Papadopoulos NE, Hwu W, Homsi J, Davies M, Cheung C, Imperiale SM, Prasad P, Hwu P
A Phase II Study of the Tolerability and Activity of Weekly Vincristine Sulfate Liposomes Injection (VSLI) in Adults with Philadelphia Chromosome-Negative (Ph-) Acute Lymphoblastic Leukemia (ALL) in Second Relapse or Progressing Following Two Antileukemia
Heffner LT, Damon LE, Larson ML, Schiller G, Stock W, Kantarjian HM, Lu B, Imperiale SM, O'Brien S
Risk of Breast Cancer Recurrence in Women Initiating Tamoxifen with CYP2D6 Inhibitors
R E Aubert, E J Stanek, J Yao, J R Teagarden, M Subar, R S Epstein, T C Skaar, Z Desta, and D A Flockhart
Vandetanib plus Docetaxel versus Docetaxel as Second-Line Treatment for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): A Randomized, Double-Blind Phase III Trial (ZODIAC)
R S Herbst, Y Sun, S Korfee, P Germonpré, N Saijo, C Zhou, J Wang, P Langmuir, S J Kennedy, and B E Johnson
Association Between Immune-Related Adverse Events (irAEs) and Disease Control or Overall Survival in Patients with Advanced Melanoma Treated with 10 mg/kg Ipilimumab in Three Phase II Clinical Trials
J Lutzky, J Wolchok, O Hamid, C Lebbe, H Pehamberger, G Linette, V de Pril, R Ibrahim, A Hoos, and S O'Day
A Phase III Study of VMPT versus VMP in Newly Diagnosed Elderly Myeloma Patients
A P Palumbo, S Bringhen, D Rossi, S Berretta, V Montefusco, J Peccatori, M Galli, A Carella, P Omedè, M Boccadoro, Italian Multiple Myeloma Network (GIMEMA)
Randomized Phase III Trial of Pixantrone Compared with Other Chemotherapeutic Agents for Third-Line Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin's Lymphoma
R Pettengell, G Narayanan, F H Mendoza, R Digumarti, H Gomez, H Gomez, P Cernohous, and I Gorbatchevsky
Outcome of Primary Tumor in Patients with Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery as Initial Treatment
G A Poultsides, E L Servais, L B Saltz, S Patil, N E Kemeny, J G Guillem, M Weiser, L K Temple, W Wong, and P B Paty